LTFU for All Cell and Gene Therapy Studies
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- AstraZeneca
- Study ID
- NCT06194461
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 130 Years
- Healthy Volunteers
- Not accepted
Interventions
- AZD5851 — BIOLOGICALSafety follow-up for up to 15 years of subjects who received AZD5851 in study NCT06084884.
- AZD0754 — BIOLOGICALSafety follow-up for up to 15 years of subjects who received AZD0754 in study NCT06267729.
Study Details
Master LTFU study will monitor the long-term safety and tolerability of cell or gene therapy study participants from AstraZeneca for up to 15 years post last cell or gene therapy treatment.
Key Dates
- Start date
- Sep 17, 2025
- Status verified
- Jun 2025
- Primary completion
- Nov 29, 2041
- Completion
- Nov 29, 2041
Study Design
- Enrollment
- 64 participants (estimated)
Arms
- Arm: AZD5851Follow-up for up to 15 years of subjects who received AZD5851 in study NCT06084884
- Arm: AZD0754Follow-up for up to 15 years of subjects who received AZD0754 in study NCT06267729
Primary Outcome Measure
Incidence of specific AEs [ Time Frame: Maximum of 15 years post dosing ]
Central Contacts
- AstraZeneca Clinical Study Information Center1-877-240-9479
Locations (18)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85054 | - |
| Research Site | Duarte | California | 91010 | - |
| Research Site | Orange | California | 92868 | - |
| Research Site | San Francisco | California | 94143 | - |
| Research Site | Washington D.C. | District of Columbia | 20007 | - |
| Research Site | Jacksonville | Florida | 32224 | - |
| Research Site | Tampa | Florida | 33612 | - |
| Research Site | Atlanta | Georgia | 30322 | - |
| Research Site | Westwood | Kansas | 66205 | - |
| Research Site | Rochester | Minnesota | 55905 | - |
| Research Site | St Louis | Missouri | 63110 | - |
| Research Site | Hackensack | New Jersey | 07601 | - |
| Research Site | New York | New York | 10065 | - |
| Research Site | Columbus | Ohio | 43210 | - |
| Research Site | Portland | Oregon | 97239 | - |
| Research Site | Philadelphia | Pennsylvania | 19104 | - |
| Research Site | Pittsburgh | Pennsylvania | 15237 | - |
| Research Site | Houston | Texas | 77030 | - |
Find similar trials in Phoenix, AZ
By condition
Related Studies
- [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate CancerRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Active Surveillance for Cancer of the Prostate (ASCaP)Recruiting · Jonsson Comprehensive Cancer Center · Los Angeles, California
- Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical ProstatectomyRecruiting · Proton Collaborative Group · Little Rock, Arkansas
- Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate CancerPHASE3 · Recruiting · Proton Collaborative Group · Scottsdale, Arizona